Ownership history in MARSHALL WACE, LLP · 25 quarters on record
This page tracks every 13F SEC filing in which MARSHALL WACE, LLP reported a position in D TENET HEALTHCARE COMMON STOCK (THC). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 444,564 | +5,529 | +1.3% | 0.09% | $90.3M | $203.04 |
| 2025 Q2 | ADDED | 439,035 | +245,536 | +126.9% | 0.09% | $77.3M | $176.00 |
| 2025 Q1 | REDUCED | 193,499 | -306,056 | -61.3% | 0.03% | $26.0M | $134.50 |
| 2024 Q4 | REDUCED | 499,555 | -240,453 | -32.5% | 0.08% | $63.1M | $126.23 |
| 2024 Q3 | ADDED | 740,008 | +26,029 | +3.6% | 0.15% | $123.0M | $166.20 |
| 2024 Q2 | ADDED | 713,979 | +48,626 | +7.3% | 0.13% | $95.0M | $133.03 |
| 2024 Q1 | ADDED | 665,353 | +16,515 | +2.5% | 0.11% | $69.9M | $105.11 |
| 2023 Q4 | REDUCED | 648,838 | -778,030 | -54.5% | 0.08% | $49.0M | $75.57 |
| 2023 Q3 | REDUCED | 1,426,868 | -854,597 | -37.5% | 0.19% | $94.0M | $65.89 |
| 2023 Q2 | ADDED | 2,281,465 | +1,646,137 | +259.1% | 0.36% | $185.7M | $81.38 |
As of 2025 Q4 — sorted by position size